Department of Chemical Sciences, University of Naples Federico II, via Cintia, 80126, Naples, Italy.
Department of Ruminant Production, Institut de Recerca i Tecnologia Agroalimentàries (IRTA), 08140, Caldes de Montbui, Spain.
Microb Cell Fact. 2018 Aug 15;17(1):126. doi: 10.1186/s12934-018-0974-z.
Recent biotechnological advancements have allowed for the adoption of Lactococcus lactis, a typical component of starter cultures used in food industry, as the host for the production of food-grade recombinant targets. Among several advantages, L. lactis has the important feature of growing on lactose, the main carbohydrate in milk and a majoritarian component of dairy wastes, such as cheese whey.
We have used recombinant L. lactis NZ9000 carrying the nisin inducible pNZ8148 vector to produce MNEI, a small sweet protein derived from monellin, with potential for food industry applications as a high intensity sweetener. We have been able to sustain this production using a medium based on the cheese whey from the production of ricotta cheese, with minimal pre-treatment of the waste. As a proof of concept, we have also tested these conditions for the production of MMP-9, a protein that had been previously successfully obtained from L. lactis cultures in standard growth conditions.
Other than presenting a new system for the recombinant production of MNEI, more compliant with its potential applications in food industry, our results introduce a strategy to valorize dairy effluents through the synthesis of high added value recombinant proteins. Interestingly, the possibility of using this whey-derived medium relied greatly on the choice of the appropriate codon usage for the target gene. In fact, when a gene optimized for L. lactis was used, the production of MNEI proceeded with good yields. On the other hand, when an E. coli optimized gene was employed, protein synthesis was greatly reduced, to the point of being completely abated in the cheese whey-based medium. The production of MMP-9 was comparable to what observed in the reference conditions.
最近的生物技术进步使得采用乳球菌(Lactococcus lactis)成为可能,乳球菌是食品工业中常用的起始培养物的典型成分,可作为生产食品级重组靶标的宿主。乳球菌具有在乳糖上生长的重要特性,乳糖是牛奶中的主要碳水化合物,也是奶酪乳清等乳制品废物的主要成分。
我们使用携带乳链菌肽诱导型 pNZ8148 载体的重组乳球菌 NZ9000 来生产 MNEI,这是一种源自莫奈林的小甜味蛋白,具有作为高甜度甜味剂在食品工业中应用的潜力。我们能够使用基于奶酪乳清的培养基来维持这种生产,而对废物进行最小的预处理。作为概念验证,我们还测试了这些条件用于生产 MMP-9 的情况,MMP-9 是一种以前在标准生长条件下从乳球菌培养物中成功获得的蛋白质。
除了提出一种更符合其在食品工业中潜在应用的 MNEI 重组生产新系统外,我们的结果还介绍了一种通过合成高附加值重组蛋白来利用乳制品废水的策略。有趣的是,使用这种乳清衍生培养基的可能性在很大程度上取决于目标基因的适当密码子用法的选择。事实上,当使用针对乳球菌进行优化的基因时,MNEI 的产量很好。另一方面,当使用针对大肠杆菌进行优化的基因时,蛋白质合成大大减少,以至于在基于奶酪乳清的培养基中完全被抑制。MMP-9 的产量与参考条件下观察到的产量相当。